08.14.26 -- Mission-Driven Professionals And Students Build America's Supply Chains

Parallel screening across multiple solid dispersion platforms early optimizes drug solubility and stability, building a strong technical foundation that prevents costly development delays.

Targeted process optimization transformed an early‑phase API with yield and impurity challenges into a scalable, high‑quality manufacturing process ready to support ongoing drug development.

Learn to overcome solubility challenges and utilize flexible development strategies to transition innovative treatments from early-phase trials to commercialization while ensuring patient safety.

Simplify the complexity of combination product development by partnering for integrated support across device design, industrialization, manufacturing, and final product assembly.

Assimilate how a scientifically grounded framework for early-phase CMC development, integrating QbD and proactive risk management, helps de-risk drug development and accelerate the journey to market.

Observe how a compound library, designed for chemical diversity and lead-like properties, uses filtering to improve hit discovery, speed development, and boost small-molecule drug discovery.

Early‑phase combination products rely on manual assembly. Clear process design, quality controls, and collaboration help clinical supply teams reduce risk and maintain trial‑ready flexibility.

Gain insight into a coordinated, around-the-clock approach that demonstrates how packaging efficiency can keep pace with urgent pharmaceutical launches and tight commercialization timelines.